From: Cough and sputum in long COVID are associated with severe acute COVID-19: a Japanese cohort study
Cough | Sputum | |||||
---|---|---|---|---|---|---|
Symptom (+) (N = 32) | Symptom (-) (N = 692) | p value | Symptom (+) (N = 36) | Symptom (-) (N = 688) | p value | |
Laboratory findings, median (IQR) | ||||||
 WBC (cells/µl) | 5070 (4125–7250) | 4846 (3900–6200) | 0.151a | 5065 (4007-7457.5) | 4840 (3900–6200) | 0.121a |
 %NEU | 73.5 (64.7–84.1) | 68.95 (60–77) | 0.004a | 72 (63.2–82.8) | 69 (60–77) | 0.012a |
 %EOS | 0 (0–1) | 0 (0–1) | 0.494a | 0 (0–1) | 0 (0–1) | 0.099a |
 %LYM | 17 (9.75-25) | 22.5 (15.8–30) | 0.006a | 19 (10.3–26) | 22.75 (15.3–30) | 0.056a |
 Cre (mg/dl) | 0.87 (0.65–1.08) | 0.8 (0.65–0.97) | 0.665a | 0.86 (0.65-1.00) | 0.81 (0.65–0.97) | 0.947a |
 LDH (IU/L) | 293 (239–402) | 229 (190–297) | < 0.001a | 278 (204–329) | 230 (191-294.5) | 0.087a |
 UA (mg/dl) | 5 (4.05–5.85) | 4.45 (3.575-5.5) | 0.107a | 5 (3.75–5.65) | 4.5 (3.5–5.5) | 0.245a |
 ferritin (ng/ml) | 423 (171.75–639.9) | 314 (150-596.9) | 0.172a | 409 (232-616.85) | 314.5 (148.75-3597.18) | 0.786a |
 KL-6 (U/ml) | 304 (217–531) | 220 (171–312) | 0.022a | 232 (177.75–336.5) | 221.5 (172-318.75) | 0.745a |
 HbA1c (%) | 6.4 (5.9–7.2) | 5.9 (5.6–6.4) | 0.031a | 6.05 (5.7–6.85) | 5.9 (5.6–6.4) | 0.539a |
 D-dimer (µg/ml) | 0.9 (0.6–1.5) | 0.8 (0.5–1.3) | 0.576a | 1.04 (0.7–1.55) | 0.8 (0.5–1.3) | 0.254a |
Imaging examination n (%) | ||||||
 Chest X-ray (GGO) | 16 (50.0) | 318 (46.0) | 0.153b | 22 (61.1) | 312 (45.3) | 0.179b |
 Chest X-ray (infiltration) | 6 (18.8) | 124 (17.9) | 0.314b | 8 (22.2) | 122 (17.7) | 0.198b |
 Chest X-ray ( ≧ 50% within 48 h) | 2 (6.3) | 49 (7.1) | 0.848b | 2 (6.3) | 49 (71.2) | 0.806b |
 Chest CT (GGO) | 28 (87.5) | 429 (62.0) | 0.004b | 31 (86.1) | 426 (61.9) | 0.128b |
 Chest CT (infiltration) | 12 (37.5) | 193 (27.9) | 0.112b | 13 (36.1) | 192 (27.9) | 0.169b |